VIAP Insider Trading Activity and SEC Form 4 Filings
VIAP insider trading summary
No open-market insider purchases or sales of VIA Pharmaceuticals, Inc. (VIAP) have been reported on SEC Form 4 in the past 12 months.
Latest VIAP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 5, 2008 | Rebecca Taub | SVP, Research & Development | Buy | $10K (32,500 @ $0.30) |
| Nov 6, 2007 | Deerfield Special Situations Fund International LTD | 10% Owner | Sell | $75K (23,234 @ $3.21) |
| Nov 6, 2007 | Deerfield Management Co | 10% Owner | Sell | $128K (39,904 @ $3.21) |
| Nov 6, 2007 | Deerfield Management Co | 10% Owner | Sell | $75K (23,234 @ $3.21) |
| Nov 6, 2007 | James E Flynn | 10% Owner | Sell | $128K (39,904 @ $3.21) |
| Nov 6, 2007 | Deerfield Capital LP | 10% Owner | Sell | $128K (39,904 @ $3.21) |
| Nov 6, 2007 | James E Flynn | 10% Owner | Sell | $75K (23,234 @ $3.21) |
| Nov 6, 2007 | Deerfield Special Situations Fund, L.P. | 10% Owner | Sell | $75K (23,234 @ $3.21) |
| Nov 6, 2007 | Deerfield Capital LP | 10% Owner | Sell | $75K (23,234 @ $3.21) |
| Nov 6, 2007 | Deerfield Special Situations Fund International LTD | 10% Owner | Sell | $128K (39,904 @ $3.21) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.